herpes

The entrance of Asahi Kasei Corporations headquarters
Pharma

Asahi Kasei makes good on AiCurus buyout with new FDA nod

Roughly half a year after the close of its deal to acquire Bayer spinout AiCurus, Asahi Kasei’s $920 million bet has paid off with an FDA nod.
Fraiser Kansteiner Oct 12, 2026 10:28am
An envelope with rejected mark Vector illustration

Manufacturing issues prompt FDA rejection of Hyloris antiviral

Mar 13, 2026 8:40am
FDA

FDA launches criminal investigation into rogue herpes vaccine research

Apr 12, 2018 9:25am
Vaccine

Participants in rogue herpes vaccine research take legal action

Mar 14, 2018 8:55am
Vaccine

Herpes researcher experiments on people before heading abroad

Nov 27, 2017 9:54am
Vaccine

Peter Thiel backs unregulated offshore herpes vaccine trial

Aug 29, 2017 10:00am